Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CIRCASSIA LIMITED

Home Clinical Trial Sponsors and OrganizationsCIRCASSIA LIMITED

CIRCASSIA LIMITED

The Bahamas

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

49

13 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

18

36.7%

Phase 1

12

24.5%

Phase 3

2

4.1%

Not Applicable

1

2.0%

Trial Status Distribution

Active, not recruiting

13

26.5%

Completed

35

71.4%

Withdrawn

1

2.0%

Clinical Trials

Trials sponsored by this organization (49)

Systemic exposure study between three formulations of orally inhaled fluticasone propionate and salmeterol xinafoate

Aug 201624 participants

Efficacy and Safety of Grass-SPIRE Registration Study

Birch-SPIRE Safety and Efficacy Study

Jul 201564 participants

Ragweed-SPIRE Follow-On Study

Apr 2015249 participants

Phase II HDM-SPIRE Safety and Efficacy Study

Sep 2014715 participants

A Double Blind, Randomised, Placebo Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects

Active, not recruiting

Jul 20141,182 participants

A Double Blind, Randomised, Placebo Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects

Active, not recruiting

Jul 20141,182 participants

A Double Blind, Randomised, Placebo Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects

Active, not recruiting

Jul 20141,182 participants

Page 1 of 7

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials49
Approvals
News

Back to Organizations